Lappe Mark (CIK 1366074) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-08). Recent activity: Buy INBX (5,895 shares), Buy INBX (6,605 shares), Buy INBX (1,100 shares), Buy INBX (500 shares), Buy INBX (1,219 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-08 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | Buy | 5,895 | $585,343 |
| 2026-09-08 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | Buy | 6,605 | $664,719 |
| 2026-09-08 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | Buy | 1,100 | $117,836 |
| 2026-09-08 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | Buy | 500 | $54,118 |
| 2026-09-08 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | Buy | 1,219 | $136,382 |
| 2026-09-08 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | Buy | 9,681 | $1.1M |
来源：SEC Form 4 申报文件 · 截至 2026-09-08